Data from a recent assessment suggest patients with HS may benefit from multiple modes of pain relief therapy.
By Kevin Kunzmann | Published on September 5, 2024
5 min read
A few different mechanisms of pain are contributing the effect felt by patients with the common skin condition hidradenitis suppurativa (HS), according to new research that which would suggest patients may benefit from multiple modes of treatment for HS.
For example, investigators from this trial found that HS lesions are insensitive to noxious heat, innocuous thermal stimuli, and light touches, while both lesions and control sites on the back of patients’ hands were found to be hypersensitive to noxious pinprick and deep pressure pain.
This research defined somatosensory profiles in individuals with HS at both affected and unaffected areas, in comparison to pain-free reference data.
“In other chronic painful conditions, effective therapy depends on the underlying pain mechanisms,” investigators wrote. “Assessment of pain mechanisms in patients with HS could aid in identifying effective pain management strategies in HS and individualizing treatments.”
The investigators recruited individuals with HS diagnoses from Emory University’s Dermatology Clinic in the time period between September 2020 and November 2021.
The rules for eligibility required the existence of at least a single tender HS lesion at the time of a patient’s testing, with exclusion criteria being conditions unrelated to HS leading to chronic pain or neuropathy and recent analgesic medication use within 24 hours of quantitative sensory testing (QST).
The design of the team’s research was cross-sectional. Prior to the QST, the investigators had a comprehensive skin exam conducted by an experienced dermatologist who ended up examining scarring tunnels through the Hurley stage.
Additionally, the dermatologist evaluated severity of HS through the use of the International Hidradenitis Suppurativa Severity Score System (IHS4), and they utilized the Hidradenitis Suppurativa Area and Severity Index–Revised for the rest of the assessment. Study participants self-reported their racial and ethnic data for the study.
The investigators used surveys in order for the research team to gauge patients’ neuropathy, pain, descriptors of pain, itch severity, HS-specific quality of life, depression, quality of life associated with skin disorders, and anxiety.
The research team used several different QST parameters, spanning both innocuous and noxious sensory perceptions of participants. These parameters included the thresholds for detecting warmth, cold, and light touch, as well as thresholds for perceiving heat, cold, pinprick, and deep pressure pain, along with suprathreshold pinprick sensitivity.
Additionally, the study examined temporal summation of pinprick sensations, paradoxical thermal sensations, and dynamic mechanical allodynia, characterized by pain triggered by light stroking of the patient’s skin.
The cross-sectional study ended up using 20 total participants, with 75 percent being women and a median age of 35.5 years. Additionally, the investigators noted that racial and ethnic backgrounds varied, with 55 percent being identified as Black, 30 percent as White, and smaller numbers as Asian or other.
Compared to the results of the healthy controls, lesions from HS were shown to have diminished sensitivity to innocuous cold as well as warmth, light touch, and noxious heat. Conversely, lesions were shown to have substantial hypersensitivity to deep pressure types of pain and cutaneous pinprick.
The investigators also noted that hypersensitivity to deep pressure pain, notably, was also seen in the control site.
Some participants with HS were found to have altered pain processing qualities commonly linked to neuropathic as well as nociplastic pain issues. Such changes were shown to have included hypersensitivity to repetitive pinpricks for 26 percent, paradoxical thermal sensations for 15 percent, and pain upon light stroking of the skin with 50 percent.
“Additional studies that evaluate the association between QST findings and other measures of small nerve fiber function across a broader population of patients with HS are needed to further elucidate cutaneous sensory changes that may contribute to pain and itch in HS,” they wrote.
An original version of this article was published by sister site HCPLive.